New Publication: Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial

Members of the SFB/TRR 289 have published a research paper about the Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine. The first authors Dr. Katharina Schmidt and Dr. Julian Kleine-Borgmann belong to the project team of Prof. Ulrike Bingel in Essen.

The publication can be downloaded here or read directly on the BMJ Open site.